Description
Ebixa is used to treat moderately severe to severe Alzheimer’s disease (AD). AD can be described as a general decline in all areas of mental ability. Ebixa belongs to a group of medicines called N-methyl-D-aspartate (NMDA) receptor antagonists.
Additional information
| brand | Lundbeck |
|---|
